These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 10024476)
1. The refolding, purification, and activity analysis of a rice Bowman-Birk inhibitor expressed in Escherichia coli. Li N; Qu LJ; Liu Y; Li Q; Gu H; Chen Z Protein Expr Purif; 1999 Feb; 15(1):99-104. PubMed ID: 10024476 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of disulfide bonds in the trypsin-reactive subdomain of a Bowman-Birk-type inhibitor of trypsin and chymotrypsin--cooperative versus autonomous refolding of subdomains. Philipp S; Kim YM; Dürr I; Wenzl G; Vogt M; Flecker P Eur J Biochem; 1998 Feb; 251(3):854-62. PubMed ID: 9490061 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds. Scarafoni A; Consonni A; Galbusera V; Negri A; Tedeschi G; Rasmussen P; Magni C; Duranti M Phytochemistry; 2008 Jun; 69(9):1820-5. PubMed ID: 18474386 [TBL] [Abstract][Full Text] [Related]
4. Generation and identification of variants with improved purification yield of Bowman-Birk protease inhibitors carrying protein binding loops. Collier KD; Vogtentanz G; Amin NS; Estabrook M; Estell DA; Fox B; Power SD; Rao R; Schmidt BF Protein Expr Purif; 2009 Dec; 68(2):146-60. PubMed ID: 19686850 [TBL] [Abstract][Full Text] [Related]
5. Refolding of a recombinant collagen-targeted TGF-beta2 fusion protein expressed in Escherichia coli. Han B; Hall FL; Nimni ME Protein Expr Purif; 1997 Nov; 11(2):169-78. PubMed ID: 9367813 [TBL] [Abstract][Full Text] [Related]
6. Small peptides derived from the Lys active fragment of the mung bean trypsin inhibitor are fully active against trypsin. Qi RF; Liu ZX; Xu SQ; Zhang L; Shao XX; Chi CW FEBS J; 2010 Jan; 277(1):224-32. PubMed ID: 19954491 [TBL] [Abstract][Full Text] [Related]
7. A rapid purification method for soybean Bowman-Birk protease inhibitor using hydrophobic-interaction chromatography. Yeboah NA; Arahira M; Udaka K; Fukazawa C Protein Expr Purif; 1996 May; 7(3):309-14. PubMed ID: 8860657 [TBL] [Abstract][Full Text] [Related]
8. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies. Richter W; Hermsdorf T; Kronbach T; Dettmer D Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709 [TBL] [Abstract][Full Text] [Related]
9. An efficient system for production of recombinant urokinase-type plasminogen activator. Tang W; Sun ZY; Pannell R; Gurewich V; Liu JN Protein Expr Purif; 1997 Dec; 11(3):279-83. PubMed ID: 9425632 [TBL] [Abstract][Full Text] [Related]
10. A Bowman-Birk inhibitor with anti-elastase activity from Lathyrus sativus L. seeds. Rocco M; Malorni L; Chambery A; Poerio E; Parente A; Di Maro A Mol Biosyst; 2011 Aug; 7(8):2500-7. PubMed ID: 21647515 [TBL] [Abstract][Full Text] [Related]
11. A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans. Ye XY; Ng TB; Rao PF Biochem Biophys Res Commun; 2001 Nov; 289(1):91-6. PubMed ID: 11708782 [TBL] [Abstract][Full Text] [Related]
12. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis. Afzal AJ; Lightfoot DA Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130 [TBL] [Abstract][Full Text] [Related]
14. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor. Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512 [TBL] [Abstract][Full Text] [Related]
15. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme. Zhao G; Meier TI; Hoskins J; Jaskunas SR Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829 [TBL] [Abstract][Full Text] [Related]
16. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors. Weder JK; Hinkers SC J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472 [TBL] [Abstract][Full Text] [Related]
17. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies. Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671 [TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis. Wang BL; Xu Y; Wu CQ; Xu YM; Wang HH Protein Expr Purif; 2005 Feb; 39(2):184-8. PubMed ID: 15642469 [TBL] [Abstract][Full Text] [Related]
19. On-column refolding purification and characterization of recombinant human interferon-lambda1 produced in Escherichia coli. Li M; Huang D Protein Expr Purif; 2007 May; 53(1):119-23. PubMed ID: 17194602 [TBL] [Abstract][Full Text] [Related]
20. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies. Jin H; Uddin MS; Huang YL; Teo WK J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]